The Federal Trade Commission (FTC), now under Republican leadership, has continued its scrutiny of Orange Book listings for device patents, signaling bipartisan concern over potential anti-competitive ...
Declutter your home and boost your bank account by strategically selling pre-owned books through the most profitable online ...
The tension between regulatory compliance and antitrust exposure in Orange Book patent listings reached a dramatic inflection point this fall. In late October, Teva Pharmaceuticals agreed to pay $35 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results